Cargando…
A Novel Drug Resistance Mechanism: Genetic Loss of Xeroderma Pigmentosum Complementation Group C (XPC) Enhances Glycolysis-Mediated Drug Resistance in DLD-1 Colon Cancer Cells
The pro-apoptotic proteins BAX and BAK are critical regulatory factors constituting the apoptosis machinery. Downregulated expression of BAX and BAK in human colorectal cancer lead to chemotherapeutic failure and poor survival rate in patients. In this study, isogenic DLD-1 colon cancer cells and th...
Autores principales: | Han, Yu, Qu, Yuan Qing, Mok, Simon Wing Fai, Chen, Juan, Xia, Cheng Lai, He, Hu Qiang, Li, Zheng, Zhang, Wei, Qiu, Cong Ling, Liu, Liang, Law, Betty Yuen Kwan, Wong, Vincent Kam Wai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746939/ https://www.ncbi.nlm.nih.gov/pubmed/31551763 http://dx.doi.org/10.3389/fphar.2019.00912 |
Ejemplares similares
-
Xeroderma Pigmentosum Complementation Group C (XPC): Emerging Roles in Non-Dermatologic Malignancies
por: Nasrallah, Nawar Al, et al.
Publicado: (2022) -
Novel Frameshift Mutations in XPC Gene Underlie Xeroderma Pigmentosum in Pakistani Families
por: Ijaz, Ambreen, et al.
Publicado: (2021) -
Xeroderma pigmentosum
por: Lehmann, Alan R, et al.
Publicado: (2011) -
Xeroderma Pigmentosum
por: Srivastava, Gautam, et al.
Publicado: (2021) -
Xeroderma pigmentosum: an updated review
por: Leung, Alexander KC, et al.
Publicado: (2022)